Despite these recent molecular insights, the full spectrum of LEMD3 mutations and their impact on TGF-β biology and their functional role in the phenotypic expression of BOS remain poorly understood. The gene discussed is TGFB1; the disease is Buschke-Ollendorff syndrome.